CRINETICS PHARMACEUTICALS, INC. Shares of Common Stock (par value $0.001 per share) Sales AgreementSales Agreement • August 13th, 2019 • Crinetics Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Crinetics Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with SVB Leerink LLC and Cantor Fitzgerald & Co. (collectively the “Agents”, and each individually an “Agent”), as follows:
